The most common genetic alterations in human prostate cancer (PC) are gene fusions involving the androgen-regulated TMPRSS2 gene and the coding sequences of a member of the ETS family transcription factor ERG, which occur in approximately half of all human prostate cancers1–3. Here, ERG is linked to prostate cancer.